Literature DB >> 29762192

Combination Antibiotics Improves Disease Activity and Alters Microbial Communities in Children With Ulcerative Colitis.

Kattayoun Kordy1, Anna Claudia Romeo2, David J Lee3, Fan Li3, Sara Zabih3, Monica Saavedra3, Nicole J Cunningham3, Nicole Tobin3, Grace M Aldrovandi3.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29762192      PMCID: PMC6103819          DOI: 10.1097/MPG.0000000000002034

Source DB:  PubMed          Journal:  J Pediatr Gastroenterol Nutr        ISSN: 0277-2116            Impact factor:   2.839


× No keyword cloud information.
  8 in total

1.  Rifaximin in patients with moderate or severe ulcerative colitis refractory to steroid-treatment: a double-blind, placebo-controlled trial.

Authors:  P Gionchetti; F Rizzello; A Ferrieri; A Venturi; C Brignola; M Ferretti; S Peruzzo; M Miglioli; M Campieri
Journal:  Dig Dis Sci       Date:  1999-06       Impact factor: 3.199

2.  Combination of oral antibiotics may be effective in severe pediatric ulcerative colitis: a preliminary report.

Authors:  Dan Turner; Arie Levine; Kaija-Leena Kolho; Ron Shaoul; Oren Ledder
Journal:  J Crohns Colitis       Date:  2014-06-20       Impact factor: 9.071

3.  Antibiotic combination therapy for steroid withdrawal in steroid-dependent ulcerative colitis.

Authors:  Shuichi Terao; Kenzo Yamashiro; Isamu Tamura; Takahiro Hirano; Toshifumi Ohkusa; Kimitoshi Kato
Journal:  Digestion       Date:  2011-01-21       Impact factor: 3.216

Review 4.  The immune response to Prevotella bacteria in chronic inflammatory disease.

Authors:  Jeppe Madura Larsen
Journal:  Immunology       Date:  2017-06-20       Impact factor: 7.397

5.  Long-term treatment of ulcerative colitis with ciprofloxacin: a prospective, double-blind, placebo-controlled study.

Authors:  U M Turunen; M A Färkkilä; K Hakala; K Seppälä; A Sivonen; M Ogren; M Vuoristo; V V Valtonen; T A Miettinen
Journal:  Gastroenterology       Date:  1998-11       Impact factor: 22.682

6.  Serial changes of cytokines in active ulcerative colitis: effects of antibiotic combination therapy.

Authors:  Kunihiko Sato; Toshimi Chiba; Toshifumi Ohkusa
Journal:  Hepatogastroenterology       Date:  2009 Jul-Aug

7.  Intestinal microbiota, microbial translocation, and systemic inflammation in chronic HIV infection.

Authors:  Duy M Dinh; Gretchen E Volpe; Chad Duffalo; Seema Bhalchandra; Albert K Tai; Anne V Kane; Christine A Wanke; Honorine D Ward
Journal:  J Infect Dis       Date:  2014-07-23       Impact factor: 5.226

8.  Double blind controlled trial of oral vancomycin as adjunctive treatment in acute exacerbations of idiopathic colitis.

Authors:  R J Dickinson; H J O'Connor; I Pinder; I Hamilton; D Johnston; A T Axon
Journal:  Gut       Date:  1985-12       Impact factor: 23.059

  8 in total
  4 in total

1.  Efficacy of Combination Antibiotic Therapy for Refractory Pediatric Inflammatory Bowel Disease.

Authors:  Jessica Breton; Arthur Kastl; Natalie Hoffmann; Rachel Rogers; Andrew B Grossman; Petar Mamula; Judith R Kelsen; Robert N Baldassano; Lindsey Albenberg
Journal:  Inflamm Bowel Dis       Date:  2019-08-20       Impact factor: 5.325

Review 2.  Antibiotics for the induction and maintenance of remission in ulcerative colitis.

Authors:  Morris Gordon; Vassiliki Sinopoulou; Ciaran Grafton-Clarke; Anthony K Akobeng
Journal:  Cochrane Database Syst Rev       Date:  2022-05-18

Review 3.  Correlation Between the Gut Microbiome and Immunotherapy Response in Inflammatory Bowel Disease: A Systematic Review of the Literature.

Authors:  Katarzyna Karpinska-Leydier; Jashvini Amirthalingam; Khadija Alshowaikh; Anuruddhika Iroshani Jayarathna; Divya Bala Anthony Manisha R Salibindla; Gokul Paidi; Huseyin Ekin Ergin
Journal:  Cureus       Date:  2021-08-01

4.  Long-term outcomes of antibiotic combination therapy for ulcerative colitis.

Authors:  Yuriko Nishikawa; Nobuhiro Sato; Shintaro Tsukinaga; Kan Uchiyama; Shigeo Koido; Dai Ishikawa; Toshifumi Ohkusa
Journal:  Ther Adv Chronic Dis       Date:  2021-07-06       Impact factor: 5.091

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.